Oppenheimer Asset Management’s Impax Laboratories, Inc. IPXL Stock Holding History

Oppenheimer Asset Management’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-20,275	Closed	-$394K	–	1195
2018 Q1	$394K	Buy	+20,275	New	+$398K	0.01%	844
2017 Q4	–	Sell	-1,189	Closed	-$24K	–	1632
2017 Q3	$24K	Buy	1,189 +18	+2%	+$344	﹤0.01%	1479
2017 Q2	$19K	Buy	1,171 +14	+1%	+$207	﹤0.01%	1478
2017 Q1	$15K	Buy	+1,157	New	+$14K	﹤0.01%	1501

Oppenheimer Asset Management's IPXL Position: Q2 2018 in Review

Oppenheimer Asset Management sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 20,275 shares — an estimated $394K sold.

Oppenheimer Asset Management first reported a position in IPXL in Q1 2017 and held it in 4 quarters. The position peaked at $394K in Q1 2018. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

Oppenheimer Asset Management reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
Oppenheimer Asset Management sold 20,275 Impax Laboratories, Inc. shares in Q2 2018, an estimated $394K.
Oppenheimer Asset Management first reported a position in Impax Laboratories, Inc. in Q1 2017 and held it in 4 quarters.
Oppenheimer Asset Management's Impax Laboratories, Inc. position peaked at $394K in Q1 2018.
1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on Oppenheimer Asset Management's 13F filing for Q2 2018, filed 10 Aug 2018.